Webinar Overview

A case-based review of diagnostic algorithms and transthyretin (TTR) therapies for cardiac amyloidosis, featuring expert guidance on navigating Veterans Affairs (VA) and federal system challenges.

Cardiac amyloidosis is an increasingly recognized cause of heart failure and other cardiovascular syndromes yet remains underdiagnosed and challenging to manage. This webinar, hosted by ACC's Federal Cardiology Member Section, provides a practical, case-based review of contemporary strategies for identifying, diagnosing and treating cardiac amyloidosis, with an emphasis on TTR disease. Expert faculty will review diagnostic algorithms, imaging pitfalls and real-world treatment considerations, including VA and federal system challenges.

Key Objectives/Learning Outcomes:

• Clinical Mastery of Diagnosis: Clinicians will learn to identify clinical "red flags" and navigate diagnostic algorithms and imaging pitfalls to tackle the underdiagnosis of cardiac amyloidosis.
• Targeted Management of TTR: Clinicians will learn practical strategies for differentiating between amyloidosis and TTR disease, with a specific focus on contemporary TTR therapies and evidence-based treatment selection.
• Federal System Optimization: Clinicians will learn how to operationalize care pathways and overcome specific access and referral barriers within the VA, Department of Defense and federal health care systems.

Webinar Recording

Webinar Participants

Moderator - Monika Do, DNP
Speaker - Alberta L. Warner, MD, FACC
Speaker - Jonathan Moreno, MD, FACC
Speaker - Nishant R. Shah, MD, MPH, FACC
Speaker - Kavita Khaira, MD, FACC